<?xml version="1.0" encoding="UTF-8"?>
<p>All DAA-na√Øve patients with chronic hepatitis C, 18 years of age or older, who started treatment with G/P at our center (comprising a tertiary care hospital and a low-threshold facility in Vienna) between October 2017 and December 2018 were included in this analysis.</p>
